Benefits Canada Staff
With drug costs rising, many stakeholders believe a new approach to drug evaluation for employer-sponsored plans is needed to manage the increase in drug spend, while ensuring plan members still have access to the beneficial medications they need.
To facilitate the exchange of ideas, Benefits Canada organized a think-tank forum titled Canadian Leadership Council on Drug Evaluation.
Interviews with many of the participants of the Canadian Leadership Council on Drug Evaluation are available on the video player.
The Canadian Leadership Council on Drug Evaluation would not have been possible without the support of our sponsors: Amgen, AstraZeneca, Novartis, Pfizer and Rx&D.